Inventor
Allan W. Rey
Inventor
Brantford, CA
Overview
Patents· 24 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds43%
A61KPreparations for medical, dental or toiletry purposes15%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations15%
C07BGeneral methods of organic chemistry15%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
C07HSugars4%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry2%
C07CAcyclic or carbocyclic compounds2%
PatentTitleYear
11,072,620Crystalline forms of Ponatinib hydrochloride202111,046,638Processes for the preparation of zuclomiphene and intermediates thereof202110,662,178Crystalline form of Olaparib202010,632,107Crystalline forms of benzoquinoline inhibitors of vesicular monoamine transporter 2202010,513,500Crystalline forms of Lesinurad201910,407,396Crystalline form of selexipag201910,183,024Crystalline forms of ibrutinib20199,382,233'Forms of vilazodone and processes for the preparation thereof'20168,883,795'Polymorphic forms of Rifaximin'20148,471,011'Preparation of acid addition salts of amine bases by solid phase—gas phase reactions'20138,188,300'Atorvastatin calcium propylene glycol solvates'20127,939,662'Amorphous ziprasidone hydrochloride (5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride) and processes to produce the same'20117,935,817'Salt form and cocrystals of adefovir dipivoxil and processes for preparation thereof'20117,834,195'Atorvastatin calcium propylene glycol solvates'20107,745,624'Preparation of acid addition salts of ziprasidone and intermediates thereof by solid phase-gas phase reactions'20107,696,183'Ibandronate sodium propylene glycol solvate and processes for the preparation thereof'20107,375,233'Process for the preparation of zonisamide and the intermediates thereof'20087,138,523'Preparation of 4-(4-fluorophenyl)-N-alkylnipecotinate esters, 4-(4-fluorophenyl)-N-arylnipecotinate esters and 4-(4-fluorophenyl)-N-aralkylnipecotinate esters'20067,087,611'Preparation of an anhydrate form of 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride (ziprasidone hydrochloride)'20066,436,956'Useful form of anhydrous paroxetine hydrochloride'20026,132,286'Preparation of 1,2,5,6-tetra-hydro-3-carboalkoxypridines such as arecoline and salts of 1,2,5,6-tetrahydro-3-carboalkoxypridines and arecoline hydrobromide'20006,008,347'N-substituted 2-azetidinones'19995,962,689'Stereoselective and useful preparation of 3-substituted 4-aryl piperidine compounds'19995,412,092'N-substituted 2-azetidinones'1995Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1995–1999Patents assigned to BRISTOL MYERS SQUIBB CO (2)· patent assignee history
1995–1999Based in Quebec, CA· patent location history
1999–2002Patents assigned to BRANTFORD CHEM INC (3)· patent assignee history
1999–2021Based in Brantford, CA· patent location history
2006–2014Patents assigned to APOTEX PHARMACHEM INC (10)· patent assignee history
2012–2014Patents assigned to REY ALLAN W (3)· patent assignee history
2016–2021Patents assigned to APOTEX INC (8)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| APOTEX PHARMACHEM INC | 10 | 2006–2014 |
| APOTEX INC | 8 | 2016–2021 |
| BRANTFORD CHEM INC | 3 | 1999–2002 |
| REY ALLAN Wself | 3 | 2012–2014 |
| BRISTOL MYERS SQUIBB CO | 2 | 1995–1999 |
Locations
| Location | Patents | Span |
|---|---|---|
| Brantford, CA | 22 | 1999–2021 |
| Quebec, CA | 2 | 1995–1999 |